Skip to Main content Skip to Navigation
Journal articles

Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)

Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02518339
Contributor : Jeannette Ouertani <>
Submitted on : Wednesday, March 25, 2020 - 10:44:00 AM
Last modification on : Monday, March 30, 2020 - 2:19:31 PM

Links full text

Identifiers

Citation

Julie Veziant, Karine Poirot, Caroline Chevarin, Lucie Cassagnes, Pierre Sauvanet, et al.. Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE). BMJ Open, BMJ Publishing Group, 2020, 10 (1), pp.e031472. ⟨10.1136/bmjopen-2019-031472⟩. ⟨hal-02518339⟩

Share

Metrics

Record views

81